연간정보 서비스
상품코드
1158127

중국의 바이오 기반 재료 시장 : 뉴스레터(분기별)

Bio-based Material Quarterly Newsletter

발행정보: | 리서치사: CCM Data & Business Intelligence | 페이지 정보: 영문 27 Pages

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

본 뉴스레터에서는 중국의 바이오 기반 재료(Bio-based Material) 시장에 대해 조사 분석했으며, 원재료부터 최종 소비까지 산업 체인 전체의 실시간 최신 정보를 제공하고 있습니다. 중국과 해외의 최신 뉴스, 최신 시장 데이터(가격, 수출입, 생산, 소비, 가동률 등), 시장 동향의 상세한 분석, 업계 관계자에 의한 전문가 해설 등이 포함되어 있습니다.

목차

헤드라인

편집 후기

정부 지시

  • 중국이 고품질 원재료 산업의 발전을 위한 시행 계획을 발표

시장 분석

  • Jindan Technology와 Kingfa가 상반기 결산을 발표
  • Zhongke Biotech & Cathay Biotech : LCDA·PA 프로젝트의 발전
  • Hisun Biomaterials가 상하이의 STAR 시장에 데뷔
  • COFCO Biotech가 생분해성 재료 프로젝트를 진전

기업 역학

  • 중국의 PLA 프로젝트 진보
  • 중국의 신바이오 기반 섬유/섬유 복합재 프로젝트
  • BBCA Biochemical이 5,000 t/a D-젖산, 3,000 t/a PLA 산업화 프로젝트를 입안
  • Zhangjiagang Jiutai가 PTT 신바이오 기반 재료를 생산
  • Jinzhu New Material과 Anhui Huizhu의 바이오 기반 프로젝트 선전

가격의 최신 동향

뉴스 개요

  • Angel Yeast와 Weigou Workshop이 중국 최대의 30,000 t/a PHA 생산 거점을 공동 설립
  • Huakang Pharma가 LA·PLA를 포함한 200만 t/a 옥수수 가공 프로젝트를 계획
  • CellUranics가 수천 만 위안의 엔젤 융자를 종료
  • GS Biotech에 의한 바이오 기반 분해성 재료 기반 프로젝트가 건설을 개시
  • Huaheng Biotech가 SA·PDO 산업화를 추진
  • Puyang Baiaomaisi가 50 t/a FDCA 파일럿 스케일 설비의 조업을 개시
  • Zhongshan의 공중합체가 전분 기반 생분해성 재료 프로젝트에서 승인
KSM 22.12.15

In Sept., China's MIIT and the other departments jointly issued an implementation plan for the high-quality development of the raw

materials industry, with the development of bio-based materials listed as one of the primary tasks.

Jindan Technology reported operating revenue and net profit for H1 with huge year-on-year increases and moving forward with a new

PLA project, the designed capacity of which has been scaled up from 10,000 t/a to 75,000 t/a; while Kingfa's net profit tumbled, deferring its plan for putting the 30,000 t/a PLA project into operation.

Zhongke Biotech and Cathay Biotech both delivered remarkable financial performance for H1 2022. The two companies have

been actively setting up production capacities of long-chain dibasic acids (LCDAs) and bio-based polyamides (PAs).

On 16 Aug., Hisun Biomaterials made IPO on the Shanghai's STAR Market, boasting fast-growing revenue and sustainable capacity

improvement of PLA over the past three years.

COFCO Biotech reported a 12.21% year-on-year increase in its net profit for H1 2022, with ongoing initiatives to propel biodegradable

materials PHA, PLA, and lactide projects.

In this Q3, China sees new developments in PLA industry, including projects in Jiangxi Keyuan and Langjing New Material, and the

proposal for 300,000 t/a PLA construction raised by Zhongke Baichuang Environmental Biotechnology (Guantao) Co., Ltd.

In Aug.-Sept., two new bio-based fibre projects were publicised and one bio-based fibre composite project was resubmitted for approval to proceed.

On 6 Sept., BBCA Biochemical published an EIA report (exposure draft) of its 5,000 t/a D-lactic acid industrialisation demonstration

project and the 3,000 t/a PLA industrialisation demonstration project.

On 31 Aug., the EI report of Zhangjiagang Jiutai's 30,000 t/a PTT new bio-based material project was approved.

In Aug., the EI reports for the bio-based new material (bamboo-based cellulose) constructions of Jinzhu New Material and Anhui Huizhu

were posted for public review, the 1st phase of each accounts for capacity of 100,000 t/a.

Bio-based Material Quarterly Newsletter provides you with real-time intelligence on China's biomaterial market.

This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire bio-based materials industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.

Table of Contents

Headline

Editor's Note

Governmental Direction

China releases implementation plan for high-quality raw material industry development

Market Analysis

Jindan Technology and Kingfa release performance reports for H1

Zhongke Biotech & Cathay Biotech: Developments in LCDA and PA projects

Hisun Biomaterials makes debut on Shanghai's STAR Market

COFCO Biotech progresses biodegradable materials projects

Company Dynamics

Advance of China's PLA projects

New bio-based fibre / fibre composite projects in China

BBCA Biochemical drafts 5,000 t/a D-lactic acid and 3,000 t/a PLA industrialisation projects

Zhangjiagang Jiutai to produce PTT new bio-based material

Publicity of bio-based projects of Jinzhu New Material and Anhui Huizhu

Price Update

News in Brief

Angel Yeast and Weigou Workshop to co-found China's biggest 30,000 t/a PHA production base

Huakang Pharma planning 2 million t/a corn processing project including LA and PLA

CellUranics closes tens of millions RMB of angel financing

GS Biotech's bio-based degradable materials base project kicks start construction

Huaheng Biotech pushes SA and PDO industrialisation

Puyang Baiaomaisi initiates operation of 50 t/a FDCA pilot-scale equipment

Zhongshan Co-polymer approved for starch-based biodegradable material project

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제